Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

A rare complication of infective endocarditis: left ventricular pseudoaneurysm masquerading as severe mitral regurgitation
Allam, Mohamed , Alsidawi, Said , Pathangey, Girish , Alsidawi, Said , Allam, Mohamed N , Sell‐Dottin, Kristen , Ibrahim, Ramzi

European Heart Journal - Cardiovascular Imaging | December 18, 2024 | Volume: 26 | Issue: 3 | Pages: 591-591

10.1093/ehjci/jeae329 | PMID 39693236 Get It

URPS Fellowship Learning Objectives for Patient Care, Medical Knowledge, and Scholarly Activity
Occhino, John A. , Yazdnay, Tajnoos, Vaccaro, Christine M. , Cramer, Meagan, Tunitsky-Bitton, Elena , Patterson, Danielle, Duecy, Erin E., Cramer, Meagan

Urogynecology | December 18, 2024 | Volume: 31 | Issue: 1 | Pages: 1-2

10.1097/spv.0000000000001601 | PMID 39692523 Get It

Knowledge-Informed Machine Learning for Cancer Diagnosis and Prognosis: A Review
Mao, Lingchao , Wang, Hairong, Hu, Leland , Tran, Nhan L. , Canoll, Peter , Swanson, Kristin R. , Li, Jing , Wang, Hairong , Hu, Leland S , Mao, Lingchao , Swanson, Kristin R , Tran, Nhan L , Li, Jing

IEEE Transactions on Automation Science and Engineering | December 18, 2024 | Volume: 22 | Issue: No issue available | Pages: 10008-10028

10.1109/tase.2024.3515839 | PMID 40893871 Get It

Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study
Ablon, Glynis , Bank, David, Kontis, Theda C., Ibrahim, Sherrif F., Palm, Melanie D., Cox, Sue Ellen , Grunebaum, Lisa D., Goldman, Mitchel P. , Humphrey, Shannon , Coquis-Knezek, Sarah, Grunebaum, Lisa, Rivers, Jason Keller

Dermatologic Surgery | December 18, 2024 | Volume: 51 | Issue: 3 | Pages: 277-283

10.1097/dss.0000000000004470 | PMID 39692332 Get It

BACKGROUND RelabotulinumtoxinA (RelaBoNT-A) is a complex-free, ready-to-use, liquid botulinum toxin A. OBJECTIVE Efficacy/safety of RelaBoNT-A treatment for lateral canthal lines (LCL). METHODS Randomized adults received RelaBoNT-A (30 U/side; n = 230) or placebo (n = 73) during a 6-month, double-blind, Ph3 study (Relabotulinumtoxin Aesthetic Development Study-2 [READY-2]). Primary end points (Month 1, maximum smile) comprised: composite ≥2-grade responder rate using concurrent LCL severity investigator live assessment (LCL-ILA) and subject live assessment (LCL-SLA); LCL-ILA 0 (none)/1 (mild) responder rate. Subject satisfaction and adverse events were also reported. RESULTS Month 1 composite ≥2-grade responder rates were 51.8% (RelaBoNT-A) and 1.4% (placebo; (p < .001). Month 1 none/mild LCL-ILA responder rates were 87.2% (RelaBoNT-A) and 11.9% (placebo; p < .001). Onset was reported Day 1 by 34%. At Month 6, LCL-ILA responder rates for RelaBoNT-A remained at 23.3% (none/mild) and 35.9% (≥1-grade improvement). Median return to baseline severity was 24.7 weeks; 64% (RelaBoNT-A group) had not returned to baseline at Month 6. RelaBoNT-A satisfaction was high through Month 6 (71%). Mild/moderate treatment-related adverse events occurred in 6.1% (RelaBoNT-A) and 5.5% (placebo). CONCLUSION RelaBoNT-A (60 U) treatment provided statistically significant improvement of moderate-to-severe LCL. One-third of subjects reported onset within 1 day and improvements were maintained through Month 6. Treatment satisfaction was high. RelaBoNT-A was well tolerated.
Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities
Peng, Yanmei , Li, Dong , Gu, Zhong, Kosuru, Nikhila, Yu, Nathan Y. , Wang, Zhichao , Leventakos, Konstantinos , Ernani, Vinicius , Wampfler, Jason A. , Luo, Yung‐Hung , Kumar, Ashok, Yang, Ping

Oncology Reports | December 18, 2024 | Volume: 53 | Issue: 2 | Pages: No page available

10.3892/or.2024.8858 | PMID 39704259 Get It

CT perfusion for lesion-symptom mapping in large vessel occlusion ischemic stroke
Garrard, James , Neuhaus, Ain , Carone, Davide , Zarrintan, Armin , Harston, George , Brinjikji, Waleed , Kallmes, David F. , Garrard, James William , Zarrintan, Armin , Brinjikji, Waleed , Joly, Olivier , Rabinstein, Alejandro A. , Huynh, Thien

Journal of NeuroInterventional Surgery | December 18, 2024 | Volume: 18 | Issue: 1 | Pages: 149-154

10.1136/jnis-2024-022501 | PMID 39694810 Get It

Background Identifying eloquent regions associated with poor outcomes based on CT perfusion (CTP) may help inform personalized decisions on selection for endovascular therapy (EVT) in patients with large vessel occlusion (LVO) ischemic stroke. This study aimed to characterize the relationship between CTP-defined hypoperfusion and National Institutes of Health Stroke Scale (NIHSS) subitem deficits. Methods Patients with anterior circulation LVO, baseline CTP, itemized NIHSS at presentation and 24 hours were included. CTP was analyzed using e-CTP (Brainomix, UK). Time to maximal contrast (Tmax) prolongation was defined as >6 s, and penumbra as the difference between Tmax and ischemic core (relative cerebral blood flow<30%). Voxel-lesion-symptom mapping was performed using sparse canonical correlation analysis. For each NIHSS subitem, and total NIHSS, the associations were plotted between Tmax voxels with baseline NIHSS, and penumbra voxels with delta NIHSS (24 hours minus baseline). Results This study included 171 patients. Total NIHSS was predicted by hypoperfusion in left frontal cortex and subcortical white matter tracts. Voxels associated with neurological recovery were symmetrical and subcortical. Limb deficits were associated with respective motor cortex regions and descending motor tracts, with negative correlation within the contralateral hemispheres. A similar but smaller cluster of voxels within the penumbra was associated with NIHSS improvement. Language impairment correlated with left frontal cortex and superior temporal gyrus voxels. With the exception of dysarthria, significant associations were observed and more diffusely distributed in all other NIHSS subitems. Conclusions These results demonstrate the feasibility of hypoperfusion-to-symptom mapping in LVO. Symptom-based mapping from presenting imaging could refine treatment decisions targeting specific neurological deficits.
What can we learn from machine learning studies on flow diverter aneurysm embolization? A systematic review
Bayraktar, Esref Alperen , Cortese, Jonathan , Jabal, Mohamed Sobhi , Ghozy, Sherief , Orscelik, Atakan , Bilgin, Cem , Kadirvel, Ramanathan , Brinjikji, Waleed , Kallmes, David F, Ghozy, Sherief , Orscelik, Atakan , Cortese, Jonathan , Bayraktar, Esref Alperen , Kallmes, David F.

Journal of NeuroInterventional Surgery | December 18, 2024 | Volume: 17 | Issue: 11 | Pages: 1168-1173

10.1136/jnis-2024-022147 | PMID 39694806 Get It

Background As the use of flow diverters has expanded in recent years, predicting successful outcomes has become more challenging for certain aneurysms. Objective To provide neurointerventionalists with an understanding of the available machine learning algorithms for predicting the success of flow diverters in occluding aneurysms. Methods This study followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the four major medical databases (PubMed, Embase, Scopus, Web of Science) were screened. The study included original research articles that evaluated the predictive abilities of various machine learning algorithms for determining the success of flow diverters in achieving aneurysm occlusion. Results Five studies out of 217 were included based on our criteria. The included studies used various variables (patient demographics, aneurysm and parent artery characteristics, flow diverter and hemodynamic-related features, and angiographic parametric imaging) to predict flow diverter treatment outcomes. The machine learning algorithms used, along with their respective accuracy rates, were as follows: logistic regression (61% and 85%), support vector machine (88%), Gaussian support vector machine (90%), linear support vector machine (85%), decision tree (80%), random forest (87%), k-nearest neighbors (83% and 85%), XGBoost (87%), CatBoost (86%), deep neural networks (77.9%), and recurrent neural networks (74%).Two studies trained the machine learning models with both all features and the most significant features. Both studies observed that the accuracy of machine learning models decreased by removing the insignificant features. Conclusion The current literature indicates that machine learning algorithms can be trained to predict the success of flow diverters with an accuracy of up to 90%.
Revisiting medical oaths: how student-driven ethical codes reflect changing values
Stein, Michael, Gruenbaum, Shaun E. , Jotkowitz, Alan, Gruenbaum, Shaun Evan, Stein, Michael

Journal of Medical Ethics | December 18, 2024 | Volume: 51 | Issue: 10 | Pages: 679-683

10.1136/jme-2024-110460 | PMID 39694800 Get It

Background Medical oaths and ethical codes play a crucial role in guiding physicians through their professional responsibilities. This study extends prior research on ethical codes created by students at the Medical School for International Health (MSIH) by analysing codes from the years 2007 to 2022. Objective The objective of this study is to evaluate changes in the ethical principles emphasised by MSIH students over time and to compare these with previous cohorts. Methods Ethical codes from MSIH classes (2007–2022) were analysed using the framework developed by Baker. This framework categorises oaths into four sections: preamble, covenant, code of duties to patients and peroration. The focus was primarily on the code of duties to patients. Quantitative analysis was used to assess the prevalence of specific ethical principles. Results The study found an increased emphasis on principles such as ‘respect for patients’ and ‘cultural competence/sensitivity’, while traditional values like ‘benevolence’ and ‘honesty’ were mentioned less frequently. New themes, including ‘patient autonomy’ and ‘cultural competence’, emerged, reflecting a shift towards patient-centred care and justice, though emerging issues like artificial intelligence ethics were not addressed. Conclusions MSIH students’ ethical codes have evolved to emphasise patient respect and cultural competence. The findings suggest a maturation in the ethical perspectives of medical students, though gaps remain in addressing contemporary challenges. Future studies should explore how ethical codes can incorporate emerging issues in healthcare.
Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches
Acott, Ted S. , Fautsch, Michael P. , Mao, Weiming , Huang, Alex S. , Kelley, Mary J. , Aga, Mini , Borrás, Terete, Bovenkamp, Diane E. , Chowdhury, Uttio Roy, Clark, Abbot F. , Dibas, Mohammed, Elliott, Michael H. , Faralli, Jennifer A., Gong, Haiyan , Kaufman, Paul L., Keller, Kate E. , Kuehn, Markus H. , Li, Hoi Lam, Lin, Shan C. , Liu, Yutao , McDonnell, Fiona , McDowell, Colleen M. , Mzyk, Philip , Nair, K. Saidas , Overby, Darryl R. , Peters, Donna M. , Raghunathan, VijayKrishna, Rao, Ponugoti Vasantha , Roddy, Gavin W. , Sharif, Najam A. , Shim, Myoung Sup , Sun, Yang , Thomson, Benjamin R. , Willoughby, Colin E. , Freddo, Thomas F., Fuchshofer, Rudolf , Hill, Kamisha R. , Karimi, Alireza , Kizhatil, Krishnakumar , Kopcyznski, Casey C., Patel, Gaurang , Pattabiraman, Padmanabhan P. , Prasanna, Ganesh , Samples, E. Griffen, Samples, John R., Steel, Cynthia, Subramanian, Preeti, Sugali, Chenna Kesavulu , Sherwood, Joseph M. , Wong, Cydney A. , Zode, Gulab , White, Elizabeth , Liu, Yutao , Ethier, C. Ross , Bhattacharya, Sanjoy K. , Du, Yiqin , Herberg, Samuel , Johnstone, Murray , Kelly, Ruth A. , Križaj, David , Lieberman, Raquel L. , McLellan, Gillian J. , Raghunathan, VijayKrishna, Rao, Ponugoti Vasantha , Toris, Carol B. , Zhang, Hao F. , Liton, Paloma B. , Peng, Michael , Reina‐Torres, Ester , Strohmaier, Clemens , Youngblood, Hannah A. , Stamer, William Daniel

Investigative Ophthalmology & Visual Science | December 18, 2024 | Volume: 65 | Issue: 14 | Pages: 32

10.1167/iovs.65.14.32 | PMID 39693082 Get It

A Protocol Investigation Comparing Transcatheter Repair with the Standard Surgical Procedure for Secondary Mitral Regurgitation
Nappi, Francesco , Singh, Sanjeet Singh Avtaar , Salsano, Antonio , Nassif, Aubin , Shingu, Yasushige , Wakasa, Satoru , Fiore, Antonio , Spadaccio, Cristiano , El‐Dean, Zein , Avtaar Singh, Sanjeet Singh , Fiore, Antonio , Nappi, Francesco

Journal of Clinical Medicine | December 18, 2024 | Volume: 13 | Issue: 24 | Pages: 7742

10.3390/jcm13247742 | PMID 39768667 Get It

Background: Secondary mitral regurgitation (SMR) is characterized by a pathological process impacting the left ventricle (LV) as opposed to the mitral valve (MV). In the absence of structural alterations to the MV, the expansion of the LV or impairment of the papillary muscles (PMs) may ensue. A number of technical procedures are accessible for the purpose of determining the optimal resolution for MR. Nevertheless, there is a dearth of rigorous data to facilitate a comparative analysis of MV replacement, MV repair (including subvalvular repair), and transcatheter mitral valve interventions (TMV-Is). The objective of this investigation is to evaluate and compare the efficacy and clinical outcomes of transcatheter mitral valve repair (TMV-r) utilizing the edge-to-edge mitral valve repair (TEER) procedure in comparison to conventional surgical mitral valve interventions (S-SMVis) in patients with secondary mitral regurgitation. Methods and analysis: A consortium of five cardiac surgery institutions from four European states and Japan have joined forces to establish a multicenter observational registry, designated TEERMISO. Patients who underwent technical procedures for SMR between January 2007 and December 2023 will be enrolled consecutively into the TEERMISO registry. The investigation team evaluated the comparative efficacy of replacement and repair techniques, utilizing both the standard surgical methodology and the transcatheter intervention. The primary clinical outcome will be the degree of left ventricular remodeling, as assessed by the left ventricular end-diastolic volume index, at 10 years. The forthcoming research will assess a variety of secondary endpoints, among which all-cause mortality will be the primary endpoint. Subsequent assessments will be made in the following order: functional status, hospitalization, neurocognition, physiological measures (echocardiographic assessment), occurrence of adverse clinical incidents, and reoperation. Ethics and dissemination: The multicenter design of the database is anticipated to reduce the potential for bias associated with institutional caseload and surgical experience. All participating centers possess an established mitral valve protocol that facilitates comprehensive follow-up and management of any delayed mitral complications following replacement surgery or surgical repair of the secondary mitral regurgitation. The data collected will provide insights into the impact of diverse surgical approaches on standard mitral valve surgery and TEER. This will facilitate the evaluation of LV remodeling over the course of long-term post-procedural follow-up. Trial Registration: ClinicalTrials.gov ID: NCT05090540; IRB ID: 202201143